Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes (Science Advances, 2022)

(untitled) - Nag, A; Dhindsa, RS; Mitchell, J; Vasavda, C; Harper, AR; Vitsios, D; Ahnmark, A; Bilican, B; Madeyski-Bengtson, K; Zarrouki, B; Zoghbi, AW; Wang, Q; et al.